id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2124-0006,FDA,FDA-2020-E-2124,"Determination of Regulatory Review
Period for Purposes of Patent
Extension; SEVENFACT",Notice,Determinations,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2022-01-04T04:59:59Z,2021-11-04T16:26:46Z,2021-24065,0,0,0900006484e17f12
FDA-2020-E-2124-0005,FDA,FDA-2020-E-2124,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T17:56:50Z,,0,0,0900006484c0fc27
FDA-2020-E-2124-0004,FDA,FDA-2020-E-2124,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-03-10T05:00:00Z,2021,3,2021-03-10T05:00:00Z,,2021-03-10T14:09:58Z,,0,0,0900006484a6630e
FDA-2020-E-2124-0003,FDA,FDA-2020-E-2124,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2021-01-04T05:00:00Z,2021,1,2021-01-04T05:00:00Z,,2021-01-04T17:13:36Z,,0,0,09000064849dc02d